The Affinity Advantage

View at publisher
Authors: Mark A. Murcko
Cited by: 3
References: 42

Abstract

Drug discovery is a complex, multiparameter optimization process. I argue that a greater emphasis on optimizing binding affinity will accelerate drug discovery. Note that "optimizing" is not always synonymous with "maximizing". While affinity is not the only property that matters, the value of optimizing drug-receptor interactions is profound and often underappreciated. Optimizing affinity provides seven distinct benefits: achieving potent tool compounds more quickly; making compounds with increased potency; making more selective compounds; optimizing drug candidates more quickly; encouraging the pursuit of more synthetically challenging compounds; expanding chemical diversity during lead optimization; and minimizing interactions with avoid-ome targets that lead to poor ADME and tox properties. Affinity, alongside other properties, should be viewed as a key strategic component throughout the entire discovery process. A checklist of practical suggestions is offered to enable project teams to more readily achieve the benefits of affinity optimization.

Fields of Study & Subjects

Computational Drug Discovery Methods Monoclonal and Polyclonal Antibodies Research Chemistry and Chemical Engineering

Publication details

Journal / source
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Volume
69
Issue
3
Pages
1963–1969
Publication date
2 February 2026
Language
EN